Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-05-17 @ 3:06 PM
Study NCT ID:
NCT02536469
Status:
COMPLETED
Last Update Posted:
2017-02-03
First Post:
2015-08-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HuMax-IL8 (Interleukin8) in Patients With Advanced Malignant Solid Tumors
Sponsor:
Bristol-Myers Squibb
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Solid Tumor | View |
Keywords: